When Worlds Collide: An Interesting Case of Rhinocerebral Mucormycosis Exacerbated by COVID-19 and Diabetic Ketoacidosis Complicated by Intraorbital Hematoma

Mucormycosis is a devastating fungal infection seen in patients who are immunosuppressed or in severe inflammatory states. Mucormycosis has been increasingly seen in the setting of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. We describe a 68-year-old male with a past medical history of uncontrolled diabetes mellitus who presented with acute vision loss and was found to have concomitant diabetic ketoacidosis (DKA) and coronavirus disease 2019 (COVID-19) infection on presentation. Rhinocerebral mucormycosis was suspected given the patient's presentation and was confirmed with an ethmoidal sinus biopsy. Our case was further complicated by the presence of cavernous sinus thrombosis, cerebral infarcts, and, later, the development of a left orbital hematoma following therapeutic anticoagulation. This case report aims to address the rare but now increasing incidence of rhinocerebral mucormycosis in the setting of COVID-19, further complicated by DKA, cerebral thrombosis, and intraorbital hematoma.

[1]  Syed Ghazanfar Ali,et al.  Newer Horizon of Mesenchymal Stem Cell–Based Therapy in the Management of SARS-CoV-2–Associated Mucormycosis: A Safe Hope for Future Medicine , 2021, Frontiers in Microbiology.

[2]  R. Gumashta,et al.  COVID19 associated mucormycosis: Is GRP78 a possible link? , 2021, Journal of Infection and Public Health.

[3]  S. Rudramurthy,et al.  Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis , 2021, Journal of fungi.

[4]  Neda Khalili,et al.  Case Report: COVID-19-associated Rhinosinusitis Mucormycosis Caused by Rhizopus arrhizus: A Rare but Potentially Fatal Infection Occurring After Treatment with Corticosteroids , 2021, The American journal of tropical medicine and hygiene.

[5]  R. Rawal,et al.  The surge in Covid related mucormycosis , 2021, Journal of Infection.

[6]  S. Joshi,et al.  Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India , 2021, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[7]  G. Tomar,et al.  Sino-orbital mucormycosis in a COVID-19 patient: A case report , 2021, International Journal of Surgery Case Reports.

[8]  V. V K,et al.  COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world? , 2021, BMJ Case Reports.

[9]  L. Sánchez-Hurtado,et al.  A Case of Fatal Rhino-Orbital Mucormycosis Associated With New Onset Diabetic Ketoacidosis and COVID-19 , 2021, Cureus.

[10]  B. Chaudhry,et al.  Rhinocerebral Mucormycosis and COVID-19 Pneumonia , 2021, Journal of medical cases.

[11]  Jinlin Song,et al.  Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study , 2016, BMC Infectious Diseases.

[12]  B. Spellberg,et al.  Pathogenesis of mucormycosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  M. Aribandi,et al.  Imaging features of invasive and noninvasive fungal sinusitis: a review. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[14]  O. Kayser,et al.  Amphotericin B , 2005, Applied Microbiology and Biotechnology.

[15]  R. Markert,et al.  Survival factors in rhino-orbital-cerebral mucormycosis. , 1994, Survey of ophthalmology.

[16]  B. A. Connor,et al.  Mucor mediastinitis. , 1979, Chest.